Gastroenterology Conferences 2022 | Hepatology Meetings 2022 | Euro Global Gastroenterology Conferences | Gastroenterology Meetings | Events | Germany | Europe | Middle East | Asia Pacific

Theme: Expanding New Horizons in Advances of Gastroenterology & Hepatology

Gastro Congress 2022

Scientific Program

Renowned Speakers

David H. Van Thiel
Rush Oak Park Hospital & Rush University Medical Center
USA

Bashar Attar
Rush University Medical Center
USA

Kamal D. Mehta
The Ohio State University College of Medicine
Uruguay

Fong-Fong Chu
Henan University of Science and Technology
USA

Bruce D Given
Arrowhead Pharmaceuticals
USA

Jay-lin Jane
Iowa State University
USA

Robert Rahimi
Baylor Scott and White Liver Consultants of Texas
USA

Marco Patti
University of North Carolina at Chapel Hill School of Medicine
USA

William J. Rowe
Medical University of Ohio at Toledo
USA

YAZAN ABU QWAIDER
Texas Tech University Health Sciences Center
USA

Carmen Cuffari
Johns Hopkins University
USA

Robert D. Odze
Gastrointestinal Pathology Brigham and Womens Hospital
USA

Pawan Mathur
Royal Free London NHS Fundation Trust
UK

Dimitar tonev
Senior medical director
UK

Tommaso Zurleni
Hospital of Busto Arsizio
Italy

Antonio Iannetti
University â€œLa Sapienzaâ€ Roma
Italy

CÃ©line Tiffon
University Hospital Bern
Switzerland

Pierluigi Fracasso
Secretary of the European Society of Primary Care Gastroenterology
Italy

Mostafa Shalaby
University of Rome Tor Vergata & Mansoura University
Italy

Giovanni Domenico Tebala
Consultant Gastrointestinal and Laparoscopic Surgeon, Nobles Hospital
Isle of Man

Wolfgang Fischbach
Hospital Aschaffenburg-Alzenau.
Germany

Oleksandr Babii
Institute of Gastroenterology of National Academy Medical Science
Ukraine

Walee Chamulitrat
University Heidelberg
Germany

Davor Stimac
Rijeka Clinical accHospital Center
Croatia

Jessica Danaher
Royal Melbourne Institute of Technology University
Australia

Ulysses Fagundes Neto
Federal University of SÃ£o Paulo (UNIFESP)
Brazil

Lynnette Ferguson
University of Auckland School of Medicine
Newzealand

LÃ¡szlÃ³ HerszÃ©nyi
Hungarian Society of Gastroenterology
Hungary

Magdy El-Salhy
Bergen University
Norway

Errawan Wiradisuria
Indonesian Society of Endolaparoscopic Surgeons (ISES)
Indonesia

Eduardo LondoÃ±o-Schimmer
American Society of Colon and Rectal Surgeons
Colombia

Gastro Congress 2022

Gastroenterology Organizers Welcomes you to attend 17^th Euro-Global Gastroenterology Conference during February 21-22, 2022 as a Webinar. The Conference highlights the theme “Expanding New Horizons in Advances of Gastroenterology and Hepatology”.

Gastro Congress 2022 is the fine platform with its properly-prepared medical software to the target market which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster periods on ultra-modern research and technological traits in the location as well as therapeutic elements.

Gastro Congress Invites Gastroenterologists, Hepetologists, Endoscopists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons and Toxicologists, Researchers, College students, Commercial enterprise delegates and younger researchers across the globe.

International-famed speakers with their closing talks at the maximum recent strategies, approaches, and the Avant grade technology in gastrointestinal therapeutics (Gastro Congress 2022) are the hallmarks of this Gastroenterology.

Scope of Gastro Congress 2022:

Gastro Congress 2022 gives a superb platform via accumulating eminent professors, Researchers, students, and delegates to change new thoughts. The Gastro Congress will cover a huge variety of subjects and allow participants to discuss approximately the control of Gastrointestinal, liver, pancreatic diseases. Gastro Congress 2022 includes keynote and plenary lectures, unique sessions (Workshop and Symposium), younger Researcher forum and Poster displays. First-rate poster presenters could be judged and awarded during the Gastro Congress 2022. To inspire huge participation from everywhere in the world conference series Ltd is presenting reduced registration charge for college kids.

Gastro Congress 2022 Highlights:

Changing Trends in Etiology of Liver diseases
Clinical Advances in Liver Diseases
Diverticular Disease
Esophageal disease
Gallbladder and biliary tract Diseases
Gastroenterology
Gastrointestinal Cancer
Gastrointestinal Endoscopy
Gastrointestinal Pathology
Gastrointestinal pharmacotherapy
Gastrointestinal therapeutics
Haemorrhoids
Hepatology
Inflammatory bowel disease
Irritable bowel syndrome
Microbiota and diseases
Neuro Gastroenterology
Pediatric Gastrointestinal Cancer

Young Research’s Awards at Gastro Congress 2022:

Gastro Congress is meant to honor prestigious award for gifted younger researchers, Scientists, younger Investigators, post-Graduate college students, submit-doctoral fellows, Trainees, Junior college in recognition of their excellent contribution in the direction of the Gastro Congress subject. The younger Scientist Awards make each attempt in imparting a robust expert development possibility for early profession academicians via meeting specialists to alternate and share their experiences on all factors of Gastroenterology.

Young Research’s Awards at Gastro Congress for the Nomination:

Younger Researcher discussion board - brilliant Masters/Ph.D./submit Doctorate thesis paintings Presentation and simplest 25 presentations acceptable at the Gastro Congress 2022

YRF Registration Benefits:

Younger Scientist Award recognition certificate and souvenir to the winners
It offers exceptional Platform in your research via oral presentations.
Find out about career development with all the trendy technology through networking.
Provide an opportunity for research interplay and hooked up senior investigators across the globe inside the subject of Gastroenterology.
It is far a fantastic privilege for young researchers to study the studies regions for increasing their studies knowledge.

Track 1: Changing Trends in Etiology of Liver Diseases

Recent biological and medical advances have clarified the mechanisms of chronic liver inflammation and succeeded in providing new therapies for various liver diseases. The aim of this issue is to summarize the current status of the basic and clinical findings in chronic liver inflammation and its complications. Such information will help develop better management programs for patients and can improve their prognosis.

9^th International Congress on Infectious Diseases February 07-08, 2022 London, UK; 10^th International Conference on Tropical Medicine and Infectious Diseases February 07-08, 2022 London, UK; 14^th Euro-Global Conference on Infectious Diseases June 24-25, 2022 Berlin, Germany; 17^thEuro-Global Gastroenterology Conference February 21-22, 2022 Webinar; 30^th International Conference on Clinical Paediatrics June 13-14, 2022 Madrid, Spain; 7^th International Conference on Bacteriology July 11-12, 2022 Vienna, Austria; 10^th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 20-21, 2022 Amsterdam, Netherlands

Relevant Societies:

USA: American Gastroenterological Association, Canadian Association of Gastroenterology, North Carolina Society of Gastroenterology, Canadian Society of Gastroenterology Nurses and Associates, Florida Gastroenterological Society, Ontario Association of Gastroenterology, Alabama Gastroenterological Society, Comparative Gastroenterology Society, American Neuro-gastroenterology and Motility Society.

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Oesophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Asia-Pacific: Gastroenterological Society of Australia, Gastroenterological Association of Thailand (GAT), Indian Society of Gastroenterology, Philippine Society of Gastroenterology, Society for Gastroenterology & Hepatology in Nigeria, Gastroenterological Society of Taiwan.

Track 2: Clinical Advances in Liver Diseases

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Paediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 3: Esophageal Disease

The esophagus is the muscular tube that carries food, and liquids from your mouth to the stomach. You may not be aware of your esophagus until you swallow something too large, too hot, or too cold. You may also notice it when something is wrong. You may feel pain or have trouble swallowing. The most common problem with the esophagus is GERD (gastro Esophageal reflux disease). With GERD, a muscle at the end of your esophagus does not close properly. This allows stomach contents to leak back, or reflux, into the esophagus and irritate it. Over time, GERD can cause damage to the esophagus. Other problems include heartburn, cancer, and esophagitis. Doctors may use various tests to make a diagnosis. These include imaging tests, an upper endoscopy, and a biopsy.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Paediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 4: Diverticular Disease

Diverticular disease is the general name for a common condition that causes small bulges (diverticula) or sacs to form in the wall of the large intestine (colon). Although these sacs can form anywhere in the colon, they are most common in the sigmoid colon (part of the large intestine closest to the rectum).

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Paediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 5: Gallbladder and Biliary Tract Diseases

Gallbladder diseases considered here include gallstones, tumours, and acute acalculous cholecystitis. Gallbladder stones are an extremely common disorder and are usually asymptomatic. Some patients experience biliary colic, an intermittent and often severe pain in the epigastrium or right upper quadrant, and at times between the scapulas because of temporary obstruction of the cystic duct with a gallstone. If the cystic duct obstruction persists, the gallbladder becomes inflamed and the patient develops cholecystitis, an acute inflammation and infection of the gallbladder.

Biliary tract diseases considered one of the most common causes of extra hepatic biliary obstruction is choledocholithiasis, with one or more stones in the common bile duct or common hepatic duct causing biliary obstruction. Cholangial carcinoma is an adenocarcinoma of the intrahepatic or extra hepatic bile duct.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Paediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 6: Gastroenterology

Gastroenterology is the study of the normal function and diseases. It contains a complete understanding of the typical action (physiology) of the gastrointestinal organs containing the programme of material through the stomach and intestine (motility), the digestion and absorption of nutrients into the body, removal of waste from the system, and the occupation of the liver as a digestive organ. It contains common and significant disorders such as colon polyps and cancer, hepatitis, Gastroesophageal reflux (heartburn), peptic ulcer disease, colitis, gallbladder and biliary tract disease, nutritional problems, Irritable Bowel Syndrome (IBS), and pancreatitis. Increases, all common activity and disease of the digestive organs are part of the study of Gastroenterology.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 7: Gastrointestinal Cancer

Gastrointestinal oncology cancer is the most common cancer in the world. It is also called gastric cancer. It refers to malignant conditions of gastrointestinal GI Cancer is the most common form of cancer. The treatment of GI Cancer depends on the type of cancer, its stage, and expansion. There numerous types of GI cancer such as liver cancer, Esophageal cancer, stomach cancer, Biliary tract cancer and various.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 8: Gastrointestinal Endoscopy

Gastrointestinal Endoscopy is a technique from side to side which the doctors can be able to lookout inside the gastrointestinal track. Gastrointestinal endoscopy can be executed either an inpatient or an outpatient setting. Through this process assess the problems of the gastrointestinal track such as ulcers, inflamed mucous, abnormal growth, bleeding in the colon. Endoscopy has various names depending on which part of the digestive system doctor seeks to inspect.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 9: Gastrointestinal Pathology

Gastrointestinal pathology is the subspecialty of surgical pathology which deals with the diagnosis and characterization of neoplastic and non-neoplastic diseases of the digestive tract and accessory organs, such as the pancreas and liver.

The main purpose of the gastrointestinal tract is the transport of food and the absorption of nutrients. Many pathologic conditions of the gastrointestinal tract impair either or both of these functions. The gastrointestinal tract, and especially the colon, is a common site of malignancy. The two main symptoms related to pathology of the gastrointestinal tract are abdominal pain and gastrointestinal haemorrhage.

The four categories of the causes of acute abdominal pain are (1) inflammation, including appendicitis, cholecystitis, pancreatitis, and diverticulitis; (2) perforation; (3) obstruction; and (4) vascular disease, including acute ischemia and ruptured abdominal aortic aneurysm. The five categories of causes of chronic abdominal pain are (1) inflammation, including peptic ulcer disease, esophagitis, inflammatory bowel disease, and chronic pancreatitis; (2) vascular disease, including chronic ischemia; (3) metabolic disease, including porphyria; (4) abdominal wall pain; and (5) functional causes, including irritable bowel syndrome. The most frequent causes of chronic abdominal pain are functional.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 10: Gastrointestinal Pharmacotherapy

Pharmacotherapy is therapy using pharmaceutical drugs, as distinguished from therapy using surgery (surgical therapy), radiation (radiation therapy), movement (physical therapy), or other modes. Among physicians, sometimes the term medical therapy refers specifically to pharmacotherapy as opposed to surgical or other therapy; for example, in oncology, medical oncology is thus distinguished from surgical oncology. Pharmacists are experts in pharmacotherapy and are responsible for ensuring the safe, appropriate, and economical use of pharmaceutical drugs. The skills required to function as a pharmacist require knowledge, training, and experience in biomedical, pharmaceutical, and clinical sciences. Pharmacology is the science that aims to continually improve pharmacotherapy. The pharmaceutical industry and academia use basic science, applied science, and translational science to create new pharmaceutical drugs.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 11: Gastrointestinal Therapeutics

Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec. Additionally, these disorders constitute a large proportion of outpatients and frequent hospital visits, globally. Gastrointestinal disorders are the medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhoea, nausea, and vomiting.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 12: Haemorrhoids

Haemorrhoids (HEM-uh-roids), also called piles, are swollen veins in your anus and lower rectum, similar to varicose veins. Haemorrhoids can develop inside the rectum (internal haemorrhoids) or under the skin around the anus (external haemorrhoids). Nearly three out of four adults will have haemorrhoids from time to time. Haemorrhoids have a number of causes, but often the cause is unknown. Fortunately, effective options are available to treat haemorrhoids. Many people get relief with home treatments and lifestyle changes.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 13: Hepatology

Hepatology is a branch of medicine concerned with the study, prevention, diagnosis, and management of diseases that affect the liver, gallbladder, biliary tree, and pancreas. The term hepatology is derived from the Greek words “hepatikos” and “logia,” which mean liver and study, respectively. Hepatitis affects millions of individuals globally and is associated with several poor outcomes including liver transplant and liver cancer. In particular, hepatitis B and hepatitis C are major causes of liver cancer, while alcohol abuse has been linked to conditions such as cirrhosis and other serious complications. The conditions hepatologists deal with most frequently are viral hepatitis and alcohol-related liver disease.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 14: Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a term for two conditions (Crohn’s disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal (GI) tract.1 Prolonged inflammation results in damage to the GI tract. The exact cause of IBD is unknown, but IBD is the result of a defective immune system. A properly functioning immune system attacks foreign organisms, such as viruses and bacteria, to protect the body. In IBD, the immune system responds incorrectly to environmental triggers, which causes inflammation of the gastrointestinal tract. There also appears to be a genetic component—someone with a family history of IBD is more likely to develop this inappropriate immune response.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 15: Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhoea or constipation, or both. IBS is a chronic condition that you will need to manage long term. Only a small number of people with IBS have severe signs and symptoms. Some people can control their symptoms by managing diet, lifestyle, and stress. More-severe symptoms can be treated with medication and counselling’s does not cause changes in bowel tissue or increase your risk of colorectal cancer.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 16: Microbiota and Diseases

In many complex diseases it is observed that commensal Microbiota composition is altered. Here are just some of the health conditions that involve our microbes. Our new understanding may lead to more focused and effective treatments. Unlike modern antibiotics, which kill good microbes along with the bad, new drugs may kill only harmful bacteria while leaving the friendly ones alone. Others may nurture friendly bacteria, helping them out compete the harmful ones.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 17: Neuro Gastroenterology

Neuro-gastroenterology encloses the study of brain, It works on "brain of the gut," which is a part of the nervous system and controls motility, endocrine secretions, and microcirculation of the gastrointestinal system the gut and their interactions in relevance to the consideration and management of gastrointestinal motility and functional gastro intestinal disorders. It mainly focuses on common Functional Gastrointestinal disorders like Irritable Bowel Syndrome, Heartburn, Abdominal Pain, Peptic Ulcer and Gallstone Pancreatitis which manages the gastrointestinal motility and Functional GIT disorders.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Track 18: Paediatric Gastrointestinal Cancer

Surgeons continue their efforts to improve their techniques to operate colorectal cancers. They now have a better understanding of what makes colorectal surgery more likely to be successful, such as making sure enough lymph nodes are removed during the operation. Esophageal cancer usually begins in the cells that line the inside of the oesophagus. Pancreatic cancer begins in the tissues of your pancreas an organ in your abdomen that lies horizontally behind the lower part of your stomach. Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. Pancreatic cancer is aggressive with few symptoms until the cancer is advanced. Symptoms may include abdominal pain, weight loss, diarrhoea, and jaundice. Treatments include surgery, chemotherapy, and radiation. Gallbladder cancer is a relatively uncommon cancer. If it is diagnosed early enough, it can be cured by removing the gallbladder, part of the liver and associated lymph nodes. Most often it is found after symptoms such as abdominal pain, jaundice and vomiting occur, and it has spread to other organs such as the liver.

Relevant Societies:

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology , British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Gastro Congress 2022 Market Analysis:

Gastroenterology is the branch of medicine Related to the GI tract (stomach and intestines) and the accessory organs of digestion (from the mouth to the anus). Focused on the digestive system and its disorders some of the conditions treated under this specialty include but are not limited to: Crohn’s disease, Gastroesophageal reflux disease (GERD), inflammatory bowel disease, irritable bowel syndrome, peptic ulcer disease, celiac disease, colon cancer, heartburn, gastric cancer, diverticulitis, and ulcerative colitis.

Gastrointestinal diseases refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.

Fg: Mostly Affected Gastroenterology diseases

The global gastrointestinal therapeutics market size is expected to reach USD 65.1 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period. Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth. According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014.

Fg: Gastroenterology market size, 2017-2025 65.1 (USD billion) by 2025

A wide range of new generation therapeutics targets that include novel small molecules and cellular therapy are currently under investigation. These include tofacitinib, ustekinumab, mongersen, and vedolizumab. This influx is anticipated to be a consequence of high prevalence of gastrointestinal diseases globally. Vedolizumab is emerging as a first-line biologic therapy for Crohn’s disease. Currently, the U.S. FDA has approved Humira, Amjevita, Cimzia, Remicade, Renflexis, Inflectra, Tysabri, and Entyvio for the treatment of Crohn’s disease.

Some studies have indicated that biologics exhibit greater long-term efficiency. According to a study conducted by University of Chicago, usage of biologics has resulted in an overall decrease in the number of surgeries by approximately 40.0%, emergency room visits by 60.0%, and hospitalizations by 50.0%.

Similarly, the National Institute carried out a study on effectiveness of infliximab in treatment for Health Research and it was reported to be a cost-effective solution in episodic treatment of active Crohn’s Disease. Increasing need for cost containment in drug development as well as administration costs is likely to fuel growth opportunities for biologics. Advent of targeted treatment alternatives has led to development of more personalized biologics.

Top Gastroenterology companies

Allergan Pharmaceuticals
Boston Scientific
Cogentix Medical
EndoChoice
EndoGastric Solutions
Evoke Pharma
Exact Sciences Corp. (colorectal cancer)
Fujifilm Medical Systems USA
gMed, a Modernizing Medicine Co.
Interscope
Johnson & Johnson
Motus GI
Olympus Corp. of the Americas
Pentax Medical USA
Physicians Endoscopy
Synergy Pharmaceuticals
Salix Pharmaceuticals
Shaili Endoscopy
Takeda Pharmaceuticals USA
US Endoscopy Group

Growing geriatric population, especially in emerging economies, is expected to drive market growth over the coming years. Furthermore, initiatives undertaken by the Centres for Disease Control and Prevention (CDC) to promote cancer screening nationwide is expected to boost market growth over the forecast period. The Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign (NCCCP) and provides funds to aid research studies and implement strategies to control colorectal cancer. This increase in initiatives for screening is expected to fuel sales of therapeutics and present lucrative growth opportunities to the market.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	February 21-22, 2022
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View